CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-07-21 | Watler Peter K. Chief Technical Officer | Option exercise | +3,991 | $2.08 | $8K | 3,991 |
| 2016-07-21 | Watler Peter K. Chief Technical Officer | Sale | −3,291 | $26.05 | $86K | 700 |
| 2016-07-21 | Watler Peter K. Chief Technical Officer | Sale | −700 | $26.48 | $19K | 0 |
| 2016-07-21 | Watler Peter K. Chief Technical Officer | Option exercise · Stock Option (right to buy) | −3,991 | 88,503 | ||
| 2016-07-20 | Watler Peter K. Chief Technical Officer | Option exercise | +50,000 | $2.08 | $104K | 50,000 |
| 2016-07-20 | Watler Peter K. Chief Technical Officer | Sale | −50,000 | $25.02 | $1.3M | 0 |
| 2016-07-20 | Watler Peter K. Chief Technical Officer | Option exercise | +23,741 | $1.42 | $34K | 23,741 |
| 2016-07-20 | Watler Peter K. Chief Technical Officer | Sale | −23,741 | $25.00 | $594K | 0 |
| 2016-07-20 | Watler Peter K. Chief Technical Officer | Option exercise · Stock Option (right to buy) | −50,000 | 92,494 | ||
| 2016-07-20 | Watler Peter K. Chief Technical Officer | Option exercise · Stock Option (right to buy) | −23,741 | 16,247 | ||
| 2016-07-11 | Watler Peter K. Chief Technical Officer | Option exercise | +43,495 | $2.08 | $91K | 43,495 |
| 2016-07-11 | Watler Peter K. Chief Technical Officer | Sale | −43,495 | $20.02 | $871K | 0 |
| 2016-07-11 | Watler Peter K. Chief Technical Officer | Option exercise · Stock Option (right to buy) | −43,495 | 0 | ||
| 2016-07-06 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +1,925 | $13.50 | $26K | 2,325 |
| 2016-07-06 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −1,925 | 132,648 | ||
| 2016-07-01 | Herman Alan C. Chief Scientific Officer | Sale | −4,250 | $16.89 | $72K | 198,115 |
| 2016-06-01 | Herman Alan C. Chief Scientific Officer | Sale | −4,250 | $18.67 | $79K | 202,365 |
| 2016-05-24 | LAWLIS V BRYAN Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-05-24 | Wahlstrom Mats Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-05-24 | Troendle August J. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 28 of 39 · 768 trades